Hospital Accuracy, Home Comfort: The Story Behind Biorithm’s Wearable CTG

Tired of clinic trips and waitlists? Hear how one medtech startup gives mothers real‑time reassurance and lets doctors intervene earlier when it matters most.

In this episode of FemTech at Work, we speak with Amrish Nair, co‑founder of Biorithm, about building a wearable at‑home cardiotocography solution and the broader mission to reduce preventable poor outcomes in pregnancy. Amrish shares the personal and technical origins of the company, why remote fetal monitoring matters, how Biorithm integrates maternal vitals (blood pressure, glucose) with fetal signals, and the clinical evidence from trials across Singapore, Australia, UK and the US. He also explains why Biorithm positions itself as medtech rather than FemTech, how they earned clinical trust through transparent data and key opinion leaders, and why AI must be grounded in high‑qualit ...